June 8th is World Brain Tumor Day

June 8th is World Brain Tumor Day. American Brain Tumor Association explains a brain tumor as a growth of abnormal cells that form in the brain. These growths can be cancerous or benign. Often the first signs of brain tumors are headaches although many experience a wide variety of have symptoms such as vision loss, seizures, and dizziness. There are more than 100 distant types of brain tumors according to the National Brain Tumor Society. Gliomas are one of the most common in those with neurofibromatosis. Tumors are often categorized in stages or as low- or high-grade tumors. Low grade tumors are thought to be slow growing tumors and high-grade tumors are thought to be fast growing. Treatment also varies greatly depending on the type, size and location of the tumors Some common treatments include radiation therapy, chemotherapy, surgical removals or even just observation for changes. Each person and treatment are different. It is always best to follow your physician’s guidance and even get second opinions if needed.

In neurofibromatosis type 1 about 15% of NF1 patients develop brain tumors called gliomas, usually during childhood. The most common gliomas associated with NF1 are astrocytoma, brain stem glioma and optic pathway glioma.

People with NF2-related schwannomatosis often develop bilateral vestibular schwannomas, also known as acoustic neuromas in the brain. They may also develop Meningiomas, a slow-growing tumor that usually develops on the surface of the brain or gliomas, including ependymomas.

A FEW NF1 & NF2/SWN RESOURCES & ARTICLES

From NF Midwest’s 2021 iNFo Fair a recorded presentation on NF1 brain tumors by Dr. Virginia Harrod.

Children’s Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research.

Drug Found To Stop Nervous System Tumor Growth [Note: This is in mice.]

NF Midwest Be iNFormed article on Brainstem Tumors in Neurofibromatosis Type 1 by Dr. Robert Listernick from 2018.

Recently published (Aug 2022) Systematic Review of Pediatric Brain Tumors in Neurofibromatosis Type 1: Status of Gene Therapy.

American Brain Tumor Association Support Groups

Recent Posts

  • Why Clinical Trials Matter, and Why They Matter Especially for NF

    Every treatment that exists today: every medication, every therapy, every breakthrough, started somewhere. It started with a question, a hypothesis, and eventually, a clinical trial. May 20 is National Clinical Trials Day, a moment to recognize the remarkable system that turns scientific ideas into real-world answers. For the NF community (patients, families, caregivers, and advocates)... Read More
  • Skylar's Story: Strength, Courage & a New Beginning 

    Some journeys begin before a child can even walk. For Skylar, hers started at just 5 months old, when she broke her left leg. It would be the first of many chapters in a story defined not by hardship, but by an extraordinary spirit that refused to be held back.  A week after that initial... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *